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Finding new methods of synthesis for saturated nitrogen 
heterocycles such as pyrrolidines remains an ongoing 
challenge for synthetic chemists due to the pharmacological 
potential of these systems.1 We have reported a method for 
the diastereoselective synthesis of pyrrolidines using 4,5-
dihydroimidazolium ylides 1, formed by in situ alkylation-
deprotonation of a dihydroimidazole, in a 1,3-dipolar 
cycloaddition to form pyrrolo[1,2-a]imidazoles.2 We have 
also applied this cycloaddition, followed by removal of the 
templating atoms, to optically active ylides to prepare 
optically active pyrrolidines in a diastereoselective 
fashion.3 This is exemplified in Scheme 1, and forms three 
bonds of the new pyrrolidine in one pot. 
Scheme 1. Dihydroimidazolium ylides in pyrrolidine synthesis. Reagents: 
i, XCH2Br, RCH=CHY, DBU; ii, NaBH3CN, H+; iii, Pd(OH)2, H2 
The diastereoselection follows our simple model of endo 
approach of dipole to dipolarophile and an anti 
conformation of the dipole,2,4 with the cyclic dipole 
providing a conformational restraint on the chiral auxiliary 
that allows simple prediction of the facial selectivity of the 
cycloaddition (Fig. 1). This successful protocol 
nevertheless uses stoichiometric base (DBU) and a reactive 
(often lachrymatory) halide. 
Figure 1. Transition state model, dihydroimidazolium ylide cycloaddition 
We wanted to generate a ‘cleaner’ catalytic procedure for 
ylide generation, and conceived the cycle shown in Scheme 
2 wherein the ylide is formed by insertion of a metal 
carbenoid formed from a diazo compound, onto the imine 
nitrogen atom lone pair of a dihydroimidazole.5 The ylide 
undergoes cycloaddition and the metal complex is liberated 
for further carbenoid formation. We report here the 
realisation of this approach to pyrroloimidazoles and thence 
potentially, as previously reported, to pyrrolidines.3 
 
Pergamon 
TETRAHEDRON 
LETTERS 
N
N
CH2Ph
Ph
i
N
N
CH2Ph
X
N
N
CH2Ph
H Y
X R
Ph
ii, iii HN Y
R
X
1
N
N
H XY
Ph
H
H
CH2Ph
R
N2↑ [M=CHX]
N
N
[M]N2CHX
R1
N
N
R1
X
R2CH=CHY
N
N
R1
H Y
X R
2
  
 
ACCEPTED MANUSCRIPT 
 
 Tetrahedron Letters  1
Scheme 2. Proposed catalytic cycle for ylide generation and cycloaddition 
The starting materials were dihydroimidazoles 2a,b. The 
former was prepared as reported previously from N-
benzyldiaminoethane,2 and N-methyl analogue 2b was 
prepared from commercial N-methyldiaminoethane and 
dimethylformamide diethyl acetal (THF, reflux, 65%).6 
Initial experiments using dihydroimidazole 2a with ethyl 
diazoacetate and copper(II) acetylacetonate Cu(acac)2 (10 
mol%) in the presence of dimethyl or diethyl fumarate 
(CH2Cl2 reflux), indeed produced low yields of the desired 
cycloadducts 3a,b (R2 = Me, 33%; R2 = Et, 25%) (Scheme 
3). Dimethyl maleate as dipolarophile also produces 
cycloadduct 3a (17%), presumably via maleate–fumarate 
equilibration prior to cycloaddition and mediated by the 
basic dihydroimidazole. Further examples were completed 
using other dipolarophiles to give cycloadducts 4 from 
fumaronitrile (23%) with copper(II) 
trifluoromethanesulfonate (copper triflate, Cu(OTf)2) 
catalyst and 5 using dimethylacetylene dicarboxylate (12% 
using Cu(acac)2; 14% using Cu(OTf)2). 
Scheme 3. Catalytic dipolar cycloadditions. Reagents: i, EtO2CCHN2, 
R2O2CCH=CHCO2R2, Cu(acac)2 or Cu(OTf)2, Yb(OTf)3 (each 10 mol%, 
see text), CH2Cl2 reflux; ii, EtO2CCHN2, NCCH=CHCN, Cu(OTf)2 (10 
mol%), CH2Cl2 reflux; iii, EtO2CCHN2, MeO2CC≡CCO2Me, Cu(acac)2 or 
Cu(OTf)2 (10 mol%) (see text), CH2Cl2 reflux. 
During these studies, and related to the maleate–fumarate 
interconversion above, a new competing mode of ylide 
generation via conjugate addition–proton transfer was 
serendipitously uncovered and extensively investigated. 
These results will be fully reported separately.7 Further 
investigations were undertaken to suppress this alternative 
pathway. Use of Rh(II) catalysis (e.g. Rh2(OAc)4) offered 
no advantage (cycloaddition of the diazo ester to the 
dipolarophile predominated), and neither did slow 
generation of the diazo compound by the base-mediated 
decomposition of ethyl glyoxylate tosylhydrazone.8 
We eventually alighted on a successful protocol: the 
dihydroimidazoles 2a or 2b were treated with the diazo 
ester ethyl diazoacetate and sub-stoichiometric copper 
triflate, in the presence of a fumarate dipolarophile and 
ytterbium triflate (CH2Cl2 reflux; 10 mol% of each of 
Cu(OTf)2 and Yb(OTf)3). The reactions were perfomed by 
simultaneous addition of separate solutions of ethyl 
diazoacetate and dimethyl fumarate or diethyl fumarate in 
CH2Cl2 dropwise over 2 h using syringe pumps, to a 
solution of the dihydroimidazole 2 in CH2Cl2 at reflux, 
containing the Cu(II) and Yb(III) catalysts and 4 Å 
molecular sieves to scavenge water. After 20 h at reflux, 
complete consumption of the dihydroimidazole 2 was 
observed and after work-up, the 1:1:1 cycloadducts 3a-d 
were isolated as principal products (Scheme 3) in yields of 
48, 30, 40 and 68%, respectively.9 
Table 1. Cycloadducts 3 and 6 from the Cu(OTf)2/Yb(OTf)3 protocol 
Dihydroimidazole Cycloadduct R1 R2 Yield % 
2a 3a CH2Ph Me 48 
2a 3b CH2Ph Et 30 
2b 3c, 6c Me Me 40, 21 
2b 3d, 6d Me Et 68, 23 
 
The relative stereochemistry of the cycloadducts 3a-d was 
determined by n.O.e difference studies using 1H NMR 
spectroscopy. For example, for cycloadduct 3a the 
following enhancements were observed (Fig. 2): irradiation 
of bridgehead proton C-7a(H) at δ 4.56 gave significant 
enhancement of C-7(H) and irradiation of C-6(H) at δ 3.89 
showed enhancement at C-5(H), demonstrating the cis-
relationships between the protons at C-7 and C-7a, and C-5 
and C-6. There is minimal interaction between C-6(H) and 
C-7(H), indicative of a trans-relationship. No interaction is 
observed between C-7a(H) or C-7(H) and C-5(H). This 
relative stereochemistry is consistent with the transition 
state model that we have previously proposed (Fig. 1), 
having an anti-dipole conformation and an endo mode of 
approach of dipolarophile to dipole (with reference to the 
activating group located at C-7 in the cycloadduct). In the 
cases of the N-methyl compounds 3c and 3d some exo 
adduct was also found, affording 6c and 6d (21% and 23% 
yield, respectively). 
Figure 2. n.O.e. interactions C-7a(H)/C-7(H), C-5(H)/C-6(H) for 
cycloadduct 3a. No significant interactions C-6(H)/C-7(H), C-5(H)/C-
7/7a(H) 
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Ytterbium(III) triflate has been reported to accelerate 1,3-
dipolar cycloadditions of carbonyl ylides with imines more 
effectively than other lanthanide triflates.10 It has been 
proposed to complex the imine to lower its LUMO, which 
accelerates the Sustmann type-II dipolar cycloaddition.11 
We tentatively propose that in the present cases, Yb(OTf)3 
can complex the imine function of the dipole; it is also 
possible that Yb(OTf)3 can additionally complex to a 
dipolarophile carbonyl group to enhance the dipolar 
cycloaddition, but we have no experimental evidence for 
these postulates. 
From preliminary atempts to scope this protocol, it would 
appear that double activation of the dipolarophile is 
preferred. For example, a reaction using dihydroimidazole 
2b, ethyl diazoacetate and ethyl propenoate did not produce 
the expected cycloadduct 7 (Scheme 4) but instead afforded 
the fumarate adduct 3d (20%), presumably via dimerization 
of the carbene formed from the diazoacetate. 
Scheme 4: Preference for doubly activated dipolarophiles. Reagents: 
EtO2CCHN2, CH2=CHCO2Et, Cu(acac)2 (10 mol%), CH2Cl2 reflux 
A further instance of the catalytic generation of an 
imidazolium ylide was found when commercial N-
methylbenzimidazole 8 was treated using the copper 
triflate/ytterbium triflate protocol in the presence of diethyl 
fumarate to afford fused tricycle 10 (47%) (Scheme 5). The 
structure of adduct 10 was deduced using NMR 
spectroscopy and confirmed by an X-ray crystal structure 
determination (Fig. 3).12,13 It appears that the presumed 
primary cycloadduct 9 undergoes spontaneous 
dehydrogenation to leave the oxidised isolated product 10. 
Scheme 5. Cycloaddition using N-methylbenzimidazole 8.Reagents: i, 
EtO2CCHN2, EtO2CCH=CHCO2Et, Cu(OTf)2, Yb(OTf)3 (each 10 mol%), 
CH2Cl2 reflux. 
An additional by-product was isolated in this reaction, the 
2-ethoxycarbonylmethylenebenzimidazole 11 (20%); we 
suggest its pathway of formation (Scheme 5) is via N-
heterocyclic carbene formation by proton transfer within 
the first-formed dipole, followed by combination with the 
diazo ester-derived carbenoid. The structure of 11 was also 
confirmed by X-ray crystal structure analysis (Fig. 4).12,13 
Figure 3. X-ray crystal structure of cycloadduct 10. 
Figure 4. X-ray crystal structure of carbene combination product 11. 
We have thus demonstrated that catalytic generation of 4,5-
dihydroimidazolium ylides is possible as an alternative to 
alkylation-deprotonation, and that the ylides react as 
expected to form pyrrolo[1,2-a]imidazoles. Optimisation of 
the detailed experimental protocol awaits further 
investigation. 
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